Lewis Turner

Lewis T. is currently working as a Senior Scientist at Biosplice Therapeutics, involved in the design and synthesis of inhibitors of the CLK/DYRK kinases. Prior to this, Lewis T. worked as a Postdoctoral Research Associate at The Scripps Research Institute, where Lewis worked on various scientific projects and as a PHD Researcher at the University of Leeds, focusing on selective inhibitors of FGFR Kinases. Lewis also worked as a Laboratory Demonstrator at the University of Leeds, overseeing practical experiments for undergraduates. Lewis T. holds a PhD in Medicinal Chemistry from the University of Leeds, a MChem in Medicinal Chemistry, and A Levels in Chemistry from Bilborough College.